Aura Biosciences, Inc. AURA

6.00 (0.15) (2.44%) as of 25 Sep
Market cap
$637.8M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

161.87 144.24 114.73 323.84
Total current assets
170.12 149.74 118.50 329.03
Property, Plant, Equpment (Net)
2.63 2.62 2.47 2.20
Long-term assets (Other)
1.05 1.24 1.29 1.91
Total non-current assets
19.90 19.69 19.17 19.10
Total Assets
190.02 169.43 137.68 348.13
Accounts Payable
1.89 1.55 2.57 2.25
Accrued Expenses
13.72 13.59 10.87 14.01
Total current liabilities
18.82 18.38 16.71 19.56
Total non-current liabilities
14.53 14.13 13.72 13.30
Total liabilities
33.36 32.52 30.43 32.86
Additional Paid In Capital
611.46 617.43 621.56 914.77
Common Stock (Net)
— — — 0.00
Retained Earnings
(454.86) (480.42) (514.10) (559.74)
Treasury Stock
— — — 39.09
Common Equity (Total)
156.67 136.91 107.25 315.27
Shareholders Equity (Total)
156.67 136.91 107.25 315.27
Shareholders Equity and Liabilities (Total)
190.02 169.43 137.68 348.13
Shares (Common)
62.99 63.59 64.15 103.48
Shareholders Equity (Tangible)
156.67 136.91 107.25 315.27
Net Debt
(161.87) (144.24) (114.73) (323.84)

Fold the line items

In millions of $ except per-share values · columns are period end dates